Future experiments will further interrogate these hypotheses about the underlying pathophysiology of anti-NMDAR encephalitis by evaluating GluN1 antibody effects on native NMDAR function and downstream intracellular signaling pathways. This evidence concerns the gene GRIN1 and encephalitis.